Wedbush Increases Earnings Estimates for Arcus Biosciences
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Equities researchers at Wedbush raised their Q1 2025 earnings estimates for shares of Arcus Biosciences in a research report issued on Tuesday, February 18th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($1.31) for the quarter, up from their previous […]
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Equities researchers at Wedbush raised their Q1 2025 earnings estimates for shares of Arcus Biosciences in a research report issued on Tuesday, February 18th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($1.31) for the quarter, up from their previous […]
